Cargando…

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data

(1) Background: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns to contribute to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties in obtaining a reliable diagnosis. (2) Methods: He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lass-Flörl, Cornelia, Knoll, Miriam, Posch, Wilfried, Joannidis, Michael, Mayerhöfer, Timo, Breitkopf, Robert, Bellmann, Romuald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818294/ https://www.ncbi.nlm.nih.gov/pubmed/36611406 http://dx.doi.org/10.3390/diagnostics13010114

Ejemplares similares

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
por: Lackner, Nina, et al.
Publicado: (2022)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata
por: Knoll, Miriam Alisa, et al.
Publicado: (2022)

COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021)

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro
por: Maurer, Elisabeth, et al.
Publicado: (2019)

Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022)

ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022)

Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
por: Zaderer, Viktoria, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
por: Sharma, Avinash, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman
por: Agrawal, Shruti, et al.
Publicado: (2021)

THE PANDEMIC'S FUNGAL REVENGE: COVID-19 ASSOCIATED PULMONARY ASPERGILLOSIS (CAPA)
por: PATEL, AZAD, et al.
Publicado: (2022)

Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients
por: Fuchs, Stefan, et al.
Publicado: (2019)

SARS-CoV-2–infected primary human airway epithelia illustrate mucus hypersecretion
por: Posch, Wilfried, et al.
Publicado: (2021)

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New
por: Lackner, Nina, et al.
Publicado: (2021)

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
por: Jäger, Michael, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
por: Fekkar, Arnaud, et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship
por: Hawkins, Lois, et al.
Publicado: (2022)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
por: Bentvelsen, Robbert G., et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

405. Incidence and Potential Risk Factors of COVID-19 Associated Pulmonary Aspergillosis (CAPA)
por: Imoto, Waki, et al.
Publicado: (2023)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity
por: Posch, Wilfried, et al.
Publicado: (2020)

Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
por: Chong, W.H., et al.
Publicado: (2021)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Ruiz-Ruigómez, María, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula
por: Naendrup, Jan-Hendrik, et al.
Publicado: (2023)

Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA
por: Cocio, Tiago Alexandre, et al.
Publicado: (2023)

Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model
por: Zaderer, Viktoria, et al.
Publicado: (2019)

Diagnosing COVID-19-associated pulmonary aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis
por: Knoll, Miriam Alisa, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis (CAPA) case series in NHS Greater Glasgow and Clyde (GGC)
por: Hassan, Shadin, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia
por: Erami, Mahzad, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles
por: Ozturk, Ali, et al.
Publicado: (2023)

1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
por: Tavakoli, Mahin, et al.
Publicado: (2020)

Mixed Etiology COVID-19 Associated Pulmonary Aspergillosis (CAPA)—A Case Report and Brief Review of the Literature
por: Toc, Dan Alexandru, et al.
Publicado: (2021)

324. COVID-19-Associated Pulmonary Aspergillosis (CAPA) at Veterans Affairs (VA) Hospitals in Southern California and Arizona
por: Fang, Michelle, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection
por: Lal, Priyanka Mohan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vrv2hl2bf5si108uc4k5e89l5a